0
Signin
countryflagUK

8082-737-676

0R15 7941.0 -0.9233% 0R1E 7597.0 3.5437% 0M69 None None% 0R2V 182.6 3.0183% 0QYR 1369.0 -0.9407% 0QYP 409.9595 -0.4953% 0LCV 141.835 -0.3268% 0RUK None None% 0RYA 1604.0 -3.3153% 0RIH 170.0 -1.0477% 0RIH 169.0619 -0.5518% 0R1O 192.5 10152.996% 0R1O None None% 0QFP None None% 0M2Z 304.7 0.7273% 0VSO None None% 0R1I None None% 0QZI 472.0 0.6397% 0QZ0 220.0 0.0% 0NZF None None%

Cizzle Biotechnology Holdings PLC

Healthcare GB CIZ

1.73GBP
0.03(1.76%)

Last update at 2024-05-09T09:04:00Z

Day Range

1.661.73
LowHigh

52 Week Range

1.364.84
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.96300M -3.95800M -0.30600M -0.02171M -1.73300M
Minority interest - - - - -
Net income -0.91200M -3.92100M -0.30600M -0.02171M -2.05700M
Selling general administrative 0.38M 0.27M 0.23M 0.02M 1.33M
Selling and marketing expenses - - - - -
Gross profit 0.00000M 0.00000M 0.00000M 0.00000M 0.04M
Reconciled depreciation - - - 0.00000M 0.62M
Ebit -0.96300M 5.36M -0.30600M -0.02171M -2.17500M
Ebitda -0.96300M 2.26M -0.15200M -0.02171M -1.55100M
Depreciation and amortization - -3.10700M 0.15M - 0.62M
Non operating income net other - - - - -
Operating income -0.96300M 2.26M -0.30600M -0.02171M -1.23200M
Other operating expenses 0.96M 0.85M 0.23M 0.02M 1.31M
Interest expense - 6.21M 0.00000M 0.00000M 0.00000M
Tax provision -0.05100M -0.03700M 0.00000M 0.00000M -0.11800M
Interest income - - - 0.00000M -
Net interest income - - - 0.00000M 0.00000M
Extraordinary items - - - - -1.73400M
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.05100M -0.03700M - -0.00000M -0.11800M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.07M
Total operating expenses 0.96M 0.85M 0.23M 0.02M 1.28M
Cost of revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.03M
Total other income expense net - -6.21400M -0.07700M 0.00000M -0.50100M
Discontinued operations - - - - -
Net income from continuing ops -0.91200M -3.92100M -0.30600M -0.02171M -1.61500M
Net income applicable to common shares -0.91200M -3.92100M -0.30600M -0.83200M -0.02789M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2.79M 1.16M 0.09M 0.02M 0.10M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.12M 0.08M 0.00600M 0.00366M 0.09M
Total liab 0.14M 0.22M 0.06M 0.00985M 0.33M
Total stockholder equity 2.64M 0.94M 0.03M 0.00663M -0.23500M
Deferred long term liab - - - - -
Other current liab 0.10M 0.11M 0.04M 0.00890M 0.12M
Common stock 0.04M 1.26M 1.24M 0.00314M 0.13M
Capital stock 0.04M 1.26M 1.24M 0.00314M 0.13M
Retained earnings -6.15300M -5.51700M -22.37100M -1.58178M -21.47700M
Other liab - - - - -
Good will - - - - 0.00000M
Other assets - - - - -
Cash 0.48M 0.88M 0.08M 0.01M 0.00400M
Cash and equivalents - - - - -
Total current liabilities 0.14M 0.22M 0.06M 0.00985M 0.33M
Current deferred revenue - - - - -
Net debt -0.47800M -0.87500M -0.08400M -0.01282M -0.00400M
Short term debt - - - - -
Short long term debt - 0.00000M - - 0.00000M
Short long term debt total - - - - -
Other stockholder equity 8.76M 5.19M 21.16M 1.59M 21.12M
Property plant equipment - - - - -
Total current assets 0.70M 0.95M 0.09M 0.02M 0.10M
Long term investments - - - - -
Net tangible assets 0.56M 0.74M -0.00800M 0.00663M 0.00334M
Short term investments - - - - -
Net receivables 0.10M 0.05M 0.00400M 0.02M 0.00288M
Long term debt - - - - -
Inventory - - - - 0.00000M
Accounts payable 0.04M 0.11M 0.02M 0.00095M 0.16M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.20M - - -
Deferred long term asset charges - - - - -
Non current assets total 2.08M 0.20M 0.00000M 0.00000M 0.00000M
Capital lease obligations - - - - 0.00000M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.12000M -0.15400M - 0.00000M 0.23M
Change to liabilities -0.07300M -0.20400M -0.00200M -0.01087M 0.00000M
Total cashflows from investing activities -0.12000M -0.15400M -0.15400M -0.15400M 0.23M
Net borrowings - -0.01000M 0.01000M 0.01000M 0.01000M
Total cash from financing activities 0.59M 2.03M 0.01000M 1.21M 0.25M
Change to operating activities - - - - -
Net income -0.96300M -3.95800M -0.30600M -0.02171M -2.05700M
Change in cash -0.39700M 0.87M -0.29400M -0.00707M -0.04000M
Begin period cash flow 0.88M 0.00700M 0.38M 0.02M 0.04M
End period cash flow 0.48M 0.88M 0.08M 0.01M 0.00400M
Total cash from operating activities -0.87200M -1.00900M -0.29400M -0.00707M -0.51300M
Issuance of capital stock 0.59M 2.04M 0.00000M 1.21M 1.08M
Depreciation - - - 0.00000M 0.62M
Other cashflows from investing activities -0.12000M -0.12000M -0.12000M -0.12000M 0.40M
Dividends paid - - - - -
Change to inventory - - - - 0.76M
Change to account receivables 0.02M 0.00700M 0.00700M 0.03M 0.00700M
Sale purchase of stock - - - 1.21M 1.08M
Other cashflows from financing activities -0.12000M -0.15400M -0.15900M -0.15900M 0.23M
Change to netincome 0.10M 3.11M 3.11M 3.08M 3.11M
Capital expenditures 0.00000M 0.20M 0.00000M 0.00000M 0.18M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.05700M -0.19700M 0.01M 0.01M 0.45M
Stock based compensation 0.15M 0.31M - 0.00000M -
Other non cash items - 2.84M - - 0.47M
Free cash flow -0.87200M -1.20900M -0.29400M -0.00707M -0.68900M

Fundamentals

  • Previous Close 1.70
  • Market Cap7.64M
  • Volume791024
  • P/E Ratio2.05
  • Dividend Yield-%
  • EBITDA-0.02644M
  • Revenue TTM0.03M
  • Revenue Per Share TTM0.08
  • Gross Profit TTM 0.03M
  • Diluted EPS TTM0.01

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
CIZ
Cizzle Biotechnology Holdings PLC		 0.03 1.76% 1.73 2.05 - 200.48 2.91 -6.732
ONT
Oxford Nanopore Technologies Ltd		 -3.1 2.71% 111.50 - - 10.88 2.75 8.77 -16.7946
GNS
Genus PLC		 18.00 0.96% 1898.00 42.59 25.71 2.08 2.46 2.31 16.39
PRTC
PureTech Health plc		 -3.0 1.35% 218.50 - - 35.55 1.04 95.87 -4.5333
AVCT
Avacta Group PLC		 -0.625 1.40% 44.08 - - 23.19 14.78 20.75 -10.4566

Reports Covered

Stock Research & News

View All

Profile

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Cizzle Biotechnology Holdings PLC

60 Gracechurch Street, London, United Kingdom, EC3V 0HR

Key Executives

Name Title Year Born
Mr. Allan John Syms Exec. Chairman 1957
Prof. Dawn Coverley Founder, Chief Scientific Officer & Non-Exec. Director 1966
Mr. Nigel R. Lee Fin. Director & Exec. Director 1962
Mr. Morgan Williams Head of Commercialisation for Yorkshire Cancer Research and Board Observer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions